This fall, Yale New Haven Health will transition to a new platform for patient education, discharge instructions and drug administration content.
Lexicomp will replace Micromedex for evidence-based drug treatment information on Sept. 27. EmmiEducate will replace ExitCare for patient education materials. The projected go-live for this transition is mid-October.
Clinicians will be able to assign information from both platforms to patients through Epic.
“The transition to Lexicomp and EmmiEducate will bring more consistency to provider and patient education and help YNHHS meet the growing demand for more accessible content that is aligned with our care signature,” said Rebecca McCray, RN, executive director, Nursing Operations, YNHHS.
Since 2015, YNHHS has partnered with Wolters Kluwer, an international provider of healthcare information, to provide tools that engage patients across the continuum of care. The EmmiEducate and Lexicomp platforms are developed and maintained by Wolters Kluwer. The platform extends the value of UpToDate clinical decision support to providers and patients, with 24/7 access to thousands of videos, articles and leaflets in up to 20 languages. The patient education materials meet system health-literacy standards and are available in print, digital, and multimedia formats. All patient education materials are reviewed regularly to ensure information is accurate, up-to-date and adheres to best practices.
The transition provides the following benefits:
More information about using Lexicomp and EmmiEducate will be available in Epic Hyperspace.
